Figure 3 shows that CD133+ cancer cells, either from the ovarian cancer line OVCAR-5 (Figure 3a), TNBC MDA-MB-231 line (Figure 3b), or from breast cancer patients (Figure 3c), all express TF. This evidence concerns the gene PROM1 and breast carcinoma.